The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

George, Ben; Kent, Matthew; Surinach, Andy; Lamarre, Neil; Cockrum, Paul

George, Ben; Kent, Matthew; Surinach, Andy; Lamarre, Neil; Cockrum, Paul.

Afiliación

George B; Department of Medical Oncology, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, United States.
Kent M; Real World Data Analytics, Genesis Research, Hoboken, NJ, United States.
Surinach A; Real World Data Analytics, Genesis Research, Hoboken, NJ, United States.
Lamarre N; Real World Data Analytics, Genesis Research, Hoboken, NJ, United States.
Cockrum P; Oncology HEOR, Ipsen, Cambridge, MA, United States.

Front Oncol ; 11: 754687, 2021.

Article en En | MEDLINE | ID: mdl-34671563

Palabras clave

CA 19-9; chemotherapy; metastatic pancreatic cancer; overall survival; prognostic factor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google